Belite Bio Inc (BLTE)
45.06
+2.68
(+6.31%)
USD |
NASDAQ |
May 20, 16:00
45.06
0.00 (0.00%)
After-Hours: 17:29
Belite Bio Price to Book Value: 13.92 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 13.89 |
| May 16, 2024 | 13.09 |
| May 15, 2024 | 13.11 |
| May 14, 2024 | 12.97 |
| May 13, 2024 | 12.87 |
| May 10, 2024 | 12.99 |
| May 09, 2024 | 13.13 |
| May 08, 2024 | 13.22 |
| May 07, 2024 | 13.34 |
| May 06, 2024 | 13.37 |
| May 03, 2024 | 13.34 |
| May 02, 2024 | 12.69 |
| May 01, 2024 | 12.67 |
| April 30, 2024 | 12.54 |
| April 29, 2024 | 12.64 |
| April 26, 2024 | 12.28 |
| April 25, 2024 | 11.74 |
| April 24, 2024 | 11.51 |
| April 23, 2024 | 11.43 |
| April 22, 2024 | 10.65 |
| April 19, 2024 | 10.32 |
| April 18, 2024 | 10.69 |
| April 17, 2024 | 9.985 |
| April 16, 2024 | 11.08 |
| April 15, 2024 | 11.30 |
| Date | Value |
|---|---|
| April 12, 2024 | 11.40 |
| April 11, 2024 | 12.32 |
| April 10, 2024 | 12.29 |
| April 09, 2024 | 12.36 |
| April 08, 2024 | 12.35 |
| April 05, 2024 | 12.24 |
| April 04, 2024 | 12.04 |
| April 03, 2024 | 12.46 |
| April 02, 2024 | 11.79 |
| April 01, 2024 | 11.40 |
| March 28, 2024 | 12.62 |
| March 27, 2024 | 13.14 |
| March 26, 2024 | 14.31 |
| March 25, 2024 | 14.39 |
| March 22, 2024 | 14.46 |
| March 21, 2024 | 14.40 |
| March 20, 2024 | 14.51 |
| March 19, 2024 | 14.67 |
| March 18, 2024 | 13.48 |
| March 15, 2024 | 12.66 |
| March 14, 2024 | 12.44 |
| March 13, 2024 | 12.51 |
| March 12, 2024 | 12.85 |
| March 11, 2024 | 14.67 |
| March 08, 2024 | 15.15 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
6.124
Minimum
Jul 11 2023
24.06
Maximum
Dec 27 2023
15.94
Average
15.48
Median
Feb 14 2024
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.95 |
| iBio Inc | 0.8069 |
| Theriva Biologics Inc | 0.2091 |
| Oragenics Inc | 8.774 |
Price to Book Value Related Metrics
| Price | 45.06 |
| Earnings Yield | -2.61% |
| Market Cap | 1.343B |